CytRxs Tamibarotene Eradicates Former NBA Players Aggressive, Advanced-Stage Leukemia

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced that an advanced form of acute promyelocytic leukemia, or APL, has been eradicated in former NBA player Ray Johnston following treatment with CytRxs experimental cancer drug tamibarotene. Mr. Johnston was afflicted with a particularly aggressive type of APL called ...